China National Medicines Corporation Ltd. Operating Income for the year ending December 31, 2024: USD 366.70 M

China National Medicines Corporation Ltd. Operating Income is USD 366.70 M for the year ending December 31, 2024, a -11.58% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • China National Medicines Corporation Ltd. Operating Income for the year ending December 31, 2023 was USD 414.71 M, a 6.19% change year over year.
  • China National Medicines Corporation Ltd. Operating Income for the year ending December 31, 2022 was USD 390.52 M, a 1.39% change year over year.
  • China National Medicines Corporation Ltd. Operating Income for the year ending December 31, 2021 was USD 385.15 M, a 31.40% change year over year.
  • China National Medicines Corporation Ltd. Operating Income for the year ending December 31, 2020 was USD 293.10 M, a -16.21% change year over year.
Key Data
Date Operating Income EBIT EBITDA Net Income